Search Results 541-550 of 19234 for Hemoglobin

1. Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined With Tumor Treatment Fields (TTF) In Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Hemoglobin > 8 g/dL. Hepatic: Direct bilirubin < 1.5 X ULN;; Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) < 3 x ULN;; For patients with ...

2. Diabetes diet: Should I avoid sweet fruits? - Mayo Clinic

   The total amount of carbohydrates in a food affects blood sugar levels more than the source of the carbohydrates — or whether that carbohydrate source is a ...

3. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

   Hemoglobin < 10 g/dL; Platelets < 25,000 cells per mm3; Total bilirubin > 3.0 mg/dL. Participating Mayo Clinic locations. Study statuses change often. Please ...

4. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   Hemoglobin ≥ g/dL. Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator. Initial treatment ...

5. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   Hemoglobin ≥ 8 g/dL. Biochemistry: Total Bilirubin within normal institutional limits. AST/SGOT and ALT/SGPT ≤ 2.5 x upper limit of normal (ULN), except ...

6. Muscle and Adipose Trafficking of Fatty Acids Under Hypoinsulinemic and Fed Conditions - Mayo Clinic

   Normal hemoglobin >11.0 g/dL for women and men will be acceptable. Women of child-bearing potential will complete a urine pregnancy test at each visit.

7. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

   Hemoglobin > 85 g/L and platelet count > 150 x 10^9/L at Screening. Part B Inclusion Criteria: 1. Has the ability to provide informed consent, and has an ...

8. Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes - Mayo Clinic

   Phase I/II: Patients must have received ≥ 2 units of RBCs for hemoglobin ≤ 9.0 g/dL within 8 weeks prior to start of treatment. Patient is non-responsive ...

9. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases - Mayo Clinic

   Hemoglobin ≥ 10 g/dL*; allowing transfusion or other intervention to achieve this minimum hemoglobin; BUN < 30 mg/dL; Creatinine < 1.7 mg/dL; Bilirubin ≤ 2.0 ...

10. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dL (obtained ≤ 14 days prior to registration);. NOTE: Packed red blood transfusion is allowed to achieve this parameter as per ...